OBM Transplantation

(ISSN 2577-5820)

OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 

Archiving: full-text archived in CLOCKSS.

Rapid publication: manuscripts are undertaken in 7 days from acceptance to publication (median values for papers published in this journal in the first half of 2019, 1-2 days of FREE language polishing time is also included in this period).

Free Publication in 2019
Current Issue: 2019  Archive: 2018 2017

Special Issue

Living Donor Liver Transplantation: Worldwide Evolution and Unmet Need

Submission Deadline: July 30, 2018 (Open)                Submit Now

Guest Editor

Dimitrios E. Giakoustidis, MD, PhD
Associate Professor of Surgery and Transplantation, Division of Transplant Surgery, Department of Surgery, Aristotle University, Hippokration General Hospital Thessaloniki, Greece
E-Mail: [email protected]
Website: http://www.placidway.com/doctor-detail/1223/Dr.-Dimitrios-Giakoustidis
Research Interests: surgical oncology; liver surgery; liver transplantation; pancreatic cancer; hcc and hcc signaling, etc

Co-Editors

Luca Toti, MD, PhD
Assistant Professor of Surgery and Transplantation, Department of Experimental Medicine and Surgery, Section of Transplantation, University of Rome Tor Vergata, Rome, Italy
E-Mail: [email protected]
Website: https://www.linkedin.com/in/luca-toti-4772143b/

Naimish N. Mehta, MD, PhD
Chief Liver Transplant Surgeon, Senior Consultant G.I & HPB Surgery, Convenor Gyan Burman Hepato-Biliary Fellowship, R. No. 2222, Department of Surgical GI & Liver Transplantation, Sir Ganga Ram Hospital, New Delhi, India
E-Mail: [email protected]
Website: www.livertransplant.co.in

About This Topic

Shortage of cadaveric donors represents a major obstacle to liver transplantation worldwide. Furthermore, the number of patients being listed for this procedure is increasing, while the number of donors remains stable. Consequently, more and more patients are dying while still on the waiting list.

Living donor liver transplantation (LDLT) is performed in both adults and children. Adult-to-adult LDLT has been developed and established primarily in Asian countries. Given the comparatively greater availability of deceased donors in Western countries, LDLT comprises a much lower percentage of transplantations compared with that in Asian countries. This has a significant impact on recipients who are currently disadvantaged by the Model for End-Stage Liver Disease (MELD)-based system of liver allocation and in some countries, the low percentage of deceased donors.

In recent years, there have been significant advances in surgical techniques. Laparoscopic or robotic harvesting of the liver, dual grafts, vein reconstruction, enhanced recovery protocols, and intra-operative bleeding control, are important issues in the field of liver transplantation. Improvements in immunosuppression, novel anti-hepatitis C drugs and hepatocellular carcinoma-targeted therapies could improve the outcome and survival of transplanted patients.

In this special issue, we welcome manuscripts concerning all current and novel knowledge in the field of living donor liver transplantation.

Planned Papers

Title: Liver LRD Transplants
Author: Wayel Jassem

Newsletter

TOP